Ketorolac is a strong pain reliever used to treat moderate to severe pain, often after surgery or injury. It works quickly to reduce pain and inflammation without being an opioid.[2] Toradol is currently approved and in use across 65 indications[4].[1]
Toradol is one of 1003 small molecule programs targeting Acute Pancreatitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Toradol
Adriamycin
Gemzar
Cymbalta
Lexiscan
Adenocard
Lupron
Recentin
Spravato
Chirocaine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details